Novartis AG ADS (NVS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

LICHTSTRASSE 35 BASEL, SWITZERLAND CH 4056

Novartis is a pharmaceutical group based in Switzerland. Co. specializes in the research, development, manufacturing and marketing of healthcare products. Co.'s portfolio includes medicines, eyecare, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer health products. Co.'s operations are organized along five business divisions: Pharmaceuticals (patent-protected prescription medicines); Alcon (vision care products); Sandoz (generic parmaceuticals); Vaccines and Diagnostics (Human vaccines and blood-testing diagnostics); and Consumer Health (Over-the-counter medicines; veterinary products for farm and companion animals; and contact lenses and lens-care products).

Data as of 2021-07-19 08:15:27 -0400
Market Cap226.229 Billion Shares Outstanding2.467 Billion Avg 30-day Volume1.509 Million
P/E Ratio28.43865 Dividend Yield3.489 EPS3.47
Price/Sales4.54 Debt to Equity2.41 EBITDA18.205 Billion
Price to Book Value4.48 Forward PE Enterprise Value259.995 Billion
Total Cash4.077 Billion Current Debt30.16 Billion Gross Profit34.446 Billion
BETA0.51192 52-week High/Low94.77 / 74.07 Next Earnings Date2021-07-21 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from NVS instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 14 -78.57% 2 (0.12%) 5 (0.29%) -60.0%
Funds Holding: 1103 1151 -4.17% 178 (10.45%) 185 (10.74%) -3.78%
13F shares: 217.77 Million 227.777 Million -4.39% 75.99 Million 81.798 Million -7.1%
% Ownership 8.8271 10.0144 -11.86% 3.0802 3.5963 -14.35%
New Positions: 71 146 -51.37% 18 23 -21.74%
Increased Positions 403 371 8.63% 63 64 -1.56%
Closed Positions 101 70 44.29% 22 16 37.5%
Reduced Positions 436 425 2.59% 63 66 -4.55%
Total Calls 2.716 Million 2.471 Million 9.95% 475.6 Thousand 523.5 Thousand -9.15%
Total Puts 1.372 Million 1.237 Million 10.99% 239.3 Thousand 442.3 Thousand -45.9%
PUT/CALL Ratio 0.51 0.5 2.0% 0.5 0.84 -40.48%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding NVS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NVS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 22:15:03 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 21:45:03 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 21:15:03 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 20:45:03 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 20:15:05 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 19:45:03 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 19:15:03 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 18:45:03 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 18:15:03 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 17:45:03 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 17:15:02 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 16:45:02 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 16:15:03 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 15:45:02 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 15:15:03 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 14:45:03 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 14:15:03 UTC -0.17 0.25 3300000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 13:45:03 UTC -0.17 0.25 2500000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 13:15:03 UTC -0.17 0.25 2500000
NOVARTIS AG-SPONSORED ADR NVS 2021-07-23 12:45:03 UTC -0.17 0.25 2500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments